跳至主要内容
临床试验/ITMCTR2100005190
ITMCTR2100005190已完成未知

Study on clinical efficacy of Qidong Huoxue Yin in the treatment of acute lung injury

The Second Affiliated Hospital of Zhengjiang University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 85(—)
性别
All

入选标准

  • 1. According to the diagnostic criteria of ALI;
  • 2. Patients admitted to our hospital for treatment and mechanical ventilation;
  • 3. Age between 18-85 years old;
  • 4. Without tumor or autoimmune disease;
  • 5. Did not participate in the clinical study of other drugs within one month;
  • 6. Volunteer to participate in this research, and sign the informed consent.

排除标准

  • 1. Pulmonary edema due to hypoproteinemia due to cardiogenic pulmonary edema, acute pulmonary embolism, liver and kidney disease, or malnutrition, atelectasis due to atelectasis, pulmonary edema due to tumor compression or pulmonary fibrosis, pulmonary edema due to upper airway obstruction, and any medical history that, according to the investigator's judgment, could interfere with the test results or increase the patient's risk of treatment;
  • 2. With drug allergy or intolerance on this test;
  • 3. Pregnant or lactating women;
  • 4. Psychiatric patients;
  • 5. Patients who are participating in clinical trials of other drugs.

研究者

发起方
The Second Affiliated Hospital of Zhengjiang University of Chinese Medicine

相似试验

Study on clinical efficacy of Qidong Huoxue Yin in... | 临床试验